AI assistant
Sending…
EUROCELL PLC — Major Shareholding Notification 2018
Nov 1, 2018
4926_mrq_2018-11-01_93ccb029-8896-4894-9ae4-c6d31c7f11d6.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0308G
Eurocell plc
01 November 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii |
EUROCELL PLC | ||||
| 2 Reason for the notification (please tick the appropriate box or boxes): | |||||
| An acquisition or disposal of voting rights | ü | ||||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
| An event changing the breakdown of voting rights | |||||
| Other (please specify): | |||||
| 3. Full name of person(s) subject to the notification obligation: iii |
Santander Asset Management UK | ||||
| 4. Full name of shareholder(s) (if different from 3.):iv |
Santander N&P UK Growth Unit Trust, Santander Max 70% Shares Unit Trust, Santander UK Growth Unit Trust; Santander Equity Income Unit Trust; Santander Dividend Income; Santander Max 30% Shares Income Portfolio; Santander Enhanced Income Portfolio; and Santander Premium Fund UK Equities |
||||
| 5. Date of the transaction and date on which the threshold is crossed or reached: v |
08/10/2018 | ||||
| 6. Date on which issuer notified: | 30/10/2018 | ||||
| 7. Threshold(s) that is/are crossed or reached: vi, vii |
5% | ||||
| 8. Notified details: | |||||||||||||||
| A: Voting rights attached to shares viii, ix | |||||||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights x | |||||||||||
| Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||||||
| GB00BVV2KN49 | 4,837,772 | 5,112,772 | |||||||||||||
| B: Qualifying Financial Instruments | |||||||||||||||
| Resulting situation after the triggering transaction | |||||||||||||||
| Type of financial instrument |
Expiration date xiii |
Exercise/ Conversion Period xiv |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|||||||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | |||||||||||||||
| Resulting situation after the triggering transaction | |||||||||||||||
| Type of financial instrument |
Exercise price | Expiration date xvii | Exercise/ Conversion period xviii |
Number of voting rights instrument refers to | % of voting rights xix, xx | ||||||||||
| Nominal | Delta | ||||||||||||||
| Total (A+B+C) | |||||||||||||||
| Number of voting rights | Percentage of voting rights | ||||||||||||||
| 5,112,772 | 5.1% | ||||||||||||||
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi |
||
| Santander N&P UK Growth Unit Trust - 0.14% Santander Max 70% Shares Unit Trust - 0.40% Santander UK Growth Unit Trust - 3.73% Santander Equity Income Unit Trust - 0.63% Santander Dividend Income - 0.01% Santander Max 30% Shares Income Portfolio - 0.03% Santander Enhanced Income Portfolio - 0.22% Santander Premium Fund UK Equities - 0.64% |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: |
||
| 12. Date on which proxy holder will cease to hold voting rights: |
||
| 13. Additional information: | ||
| 14. Contact name: | Veselin Georgiev Rangelov | |
| 15. Contact telephone number: | +44 (0) 2 0791 40 729 | |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
HOLFSFFSFFASELF
More from EUROCELL PLC
Director's Dealing
2026
May 18
Declaration of Voting Results & Voting Rights Announcements
2026
May 15
Declaration of Voting Results & Voting Rights Announcements
2026
May 14
Regulatory Filings
2026
May 14
Director's Dealing
2026
May 1
Board/Management Information
2026
Apr 17
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Earnings Release
2026
Mar 19
Report Publication Announcement
2026
Mar 16